Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13734-41-3

Post Buying Request

13734-41-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13734-41-3 Usage

Uses

Different sources of media describe the Uses of 13734-41-3 differently. You can refer to the following data:
1. Boc-Vgl-OH is an important organic intermediate to synthetize substituted vinylglycine products.
2. N-tert-butoxycarbonyl-L-proline is used in amino acid conjugates as proteasome inhibitors.
3. N-Boc-L-valine is used in the multi-peptide synthesis and serves as the amino acid protection monomer.

Chemical Properties

N-tert-butoxycarbonyl-L-proline is white fine crystalline powder

Check Digit Verification of cas no

The CAS Registry Mumber 13734-41-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,7,3 and 4 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 13734-41:
(7*1)+(6*3)+(5*7)+(4*3)+(3*4)+(2*4)+(1*1)=93
93 % 10 = 3
So 13734-41-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H19NO4/c1-6(2)7(8(12)13)11-9(14)15-10(3,4)5/h6-7H,1-5H3,(H,11,14)(H,12,13)/p-1/t7-/m0/s1

13734-41-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B1333)  N-(tert-Butoxycarbonyl)-L-valine  >99.0%(T)

  • 13734-41-3

  • 5g

  • 160.00CNY

  • Detail
  • TCI America

  • (B1333)  N-(tert-Butoxycarbonyl)-L-valine  >99.0%(T)

  • 13734-41-3

  • 25g

  • 480.00CNY

  • Detail
  • Alfa Aesar

  • (A16007)  N-Boc-L-valine, 98+%   

  • 13734-41-3

  • 1g

  • 66.0CNY

  • Detail
  • Alfa Aesar

  • (A16007)  N-Boc-L-valine, 98+%   

  • 13734-41-3

  • 5g

  • 293.0CNY

  • Detail
  • Alfa Aesar

  • (A16007)  N-Boc-L-valine, 98+%   

  • 13734-41-3

  • 25g

  • 767.0CNY

  • Detail
  • Aldrich

  • (15528)  Boc-Val-OH  ≥99.0% (T)

  • 13734-41-3

  • 15528-25G

  • 1,278.81CNY

  • Detail
  • Aldrich

  • (15528)  Boc-Val-OH  ≥99.0% (T)

  • 13734-41-3

  • 15528-100G

  • 2,427.75CNY

  • Detail

13734-41-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-2-(Boc-amino)-3-methylbutyric acid

1.2 Other means of identification

Product number -
Other names N-BOC-L-VALINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13734-41-3 SDS

13734-41-3Synthetic route

L-valine
72-18-4

L-valine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; water100%
With sodium hydroxide In 1,4-dioxane; water at 0℃;100%
With sodium hydroxide In tetrahydrofuran; water at 20℃; for 16h;100%
Boc-Val-NHNHPh
95499-91-5

Boc-Val-NHNHPh

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With oxygen In acetonitrile for 16h; tyrosinase, phosphate buffer pH 7;99%
With phosphate buffer; oxygen; tyrosinase In water; acetonitrile at 20℃; for 16h; pH=7.0;99%
Boc-Val-O-t-Bu
128359-98-8

Boc-Val-O-t-Bu

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With cerium(III) chloride; sodium iodide In acetonitrile for 6h; Heating;99%
With water; iodine In acetonitrile for 5h; Heating;89%
L-valine
72-18-4

L-valine

2-t-butoxycarbonyloxy-3,6-diisopropylpyrazine
104272-92-6

2-t-butoxycarbonyloxy-3,6-diisopropylpyrazine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In water; acetonitrile for 24h; Ambient temperature;98%
(S)-(1,1-dioxido-4-oxo-3-phenyl-4H-thiochromen-2-yl)methyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate

(S)-(1,1-dioxido-4-oxo-3-phenyl-4H-thiochromen-2-yl)methyl 2-((tert-butoxycarbonyl)amino)-3-methylbutanoate

A

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

B

C16H10O3S
1033736-87-6

C16H10O3S

Conditions
ConditionsYield
In chloroform-d1 for 0.233333h; Photolysis; Inert atmosphere;A 97%
B n/a
L-valine
72-18-4

L-valine

tert-butyl pyridin-2-yl carbonate
89985-91-1

tert-butyl pyridin-2-yl carbonate

A

2-hydroxypyridin
142-08-5

2-hydroxypyridin

B

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In water; N,N-dimethyl-formamide for 9h; Ambient temperature;A n/a
B 92%
L-valine
72-18-4

L-valine

2,2-dimethylpropanoic anhydride
1538-75-6

2,2-dimethylpropanoic anhydride

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
Stage #1: L-valine With sodium hydroxide In tetrahydrofuran; water at 0 - 20℃;
Stage #2: 2,2-dimethylpropanoic anhydride In tetrahydrofuran; water at 0 - 20℃; for 12h;
90%
((S)-1-benzylcarbamoyl-2-methyl-propyl)-carbamic acid tert-butyl ester
66447-55-0

((S)-1-benzylcarbamoyl-2-methyl-propyl)-carbamic acid tert-butyl ester

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With formic acid; potassium hydroxide In ethanol at 70℃; for 1h;89%
With hydrogen; palladium on activated charcoal
N-tert-butoxycarbonyl-L-valine methyl ester
58561-04-9

N-tert-butoxycarbonyl-L-valine methyl ester

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With lithium hydroxide In methanol for 8h;85%
With water; lithium hydroxide In methanol for 4h;
L-valine
72-18-4

L-valine

tert-butyl 2-oxo-1,3-oxazole-3(2H)-carboxylate
75844-68-7

tert-butyl 2-oxo-1,3-oxazole-3(2H)-carboxylate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With dmap; triethylamine In 1,4-dioxane; water for 15h; Ambient temperature;84%
N-(tert-butoxycarbonyl)valine 1,1-dimethylallyl ester
851714-00-6

N-(tert-butoxycarbonyl)valine 1,1-dimethylallyl ester

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With 4-methyl-morpholine; tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran at 25℃;84%
L-valine
72-18-4

L-valine

1,2,2,2-Tetrachloroethyl tert-Butyl Carbonate
98015-52-2

1,2,2,2-Tetrachloroethyl tert-Butyl Carbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane; water at 20℃; pH=9.2;80%
L-valine
72-18-4

L-valine

O-(tert-butyl) S-(pyridin-2-yl)carbonothioate
105678-24-8

O-(tert-butyl) S-(pyridin-2-yl)carbonothioate

A

2-Mercaptopyridine
2637-34-5

2-Mercaptopyridine

B

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In water; N,N-dimethyl-formamide for 12h; Ambient temperature;A n/a
B 80%
D-Val-OH
640-68-6

D-Val-OH

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In water; acetone at 25℃; for 4.5h;70%
L-valine
72-18-4

L-valine

t-butyl S-3,6-diisopropylpyrazin-2-ylthiolcarbonate
104272-95-9

t-butyl S-3,6-diisopropylpyrazin-2-ylthiolcarbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With dmap; triethylamine In water; acetonitrile for 24h; Ambient temperature;63%
L-valine
72-18-4

L-valine

tert-Butyl 4-nitrophenyl carbonate
13303-10-1

tert-Butyl 4-nitrophenyl carbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With sodium carbonate; tert-butyl alcohol
N-(tert-butyloxycarbonyl) azide
1070-19-5

N-(tert-butyloxycarbonyl) azide

L-valine
72-18-4

L-valine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; water
With triethylamine In water; N,N-dimethyl-formamide
tert-butyl (quinolin-8-yl)carbonate
18595-55-6

tert-butyl (quinolin-8-yl)carbonate

L-valine
72-18-4

L-valine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With sodium hydroxide In N,N-dimethyl-formamide
L-valine
72-18-4

L-valine

tert-butyl fluoroformate
18595-34-1

tert-butyl fluoroformate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With sodium hydroxide In N,N-dimethyl-formamide
L-valine
72-18-4

L-valine

1,1-dimethylethyl 2,4,5-trichlorophenyl carbonate
16965-08-5

1,1-dimethylethyl 2,4,5-trichlorophenyl carbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

t-butylpentachlorophenyl carbonate
18942-25-1

t-butylpentachlorophenyl carbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In chloroform; N,N-dimethyl-formamide
L-valine
72-18-4

L-valine

tert-butyl chloroformate
24608-52-4

tert-butyl chloroformate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With sodium hydroxide
With sodium hydroxide In 1,4-dioxane for 16h; Ambient temperature;
With magnesium oxide In diethyl ether; water
phosgene
75-44-5

phosgene

L-valine
72-18-4

L-valine

lithium tert-butoxide
1907-33-1

lithium tert-butoxide

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
Yield given. Multistep reaction;
L-valine
72-18-4

L-valine

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile
58632-95-4

2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine In 1,4-dioxane; water for 4h; Ambient temperature;
L-valine
72-18-4

L-valine

1-(t-butoxycarbonyl)-1,2,4-triazolo<4,3-a>pyridinium-3-olate
50739-44-1

1-(t-butoxycarbonyl)-1,2,4-triazolo<4,3-a>pyridinium-3-olate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With pyridine; sodium hydroxide In acetone for 3h; Ambient temperature;
L-valine
72-18-4

L-valine

tert-butyl α-methoxyvinyl carbonate
81616-10-6

tert-butyl α-methoxyvinyl carbonate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With triethylamine 1.) dioxane, water, room temp., 30 min, 2.) 20 deg C, 5 h; Yield given. Multistep reaction;
L-valine
72-18-4

L-valine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

(S)-4-nitrophenyl 2-(tert-butoxycarbonylamino)-3-methylbutanoate
16948-40-6

(S)-4-nitrophenyl 2-(tert-butoxycarbonylamino)-3-methylbutanoate

A

4-nitro-phenol
100-02-7

4-nitro-phenol

B

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With N+C5AlaHis2C16; phosphate buffer pH=7.47; In water at 15 - 40℃; Rate constant; Kinetics; Mechanism; enantioselectivity in ester hydrolysis; other micelle- and vesicle- catalysts; ΔH (excit.); ΔS (excit.); ΔG (excit.);;
dicyclohexylammonium Boc-L-valinate
16944-17-5, 61315-58-0, 102213-00-3

dicyclohexylammonium Boc-L-valinate

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Conditions
ConditionsYield
With sulfonic acid In ethyl acetate
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

methyl iodide
74-88-4

methyl iodide

Boc-N-Me-Val-OH
45170-31-8

Boc-N-Me-Val-OH

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran at 0 - 23℃; Inert atmosphere;100%
With sodium hydride In tetrahydrofuran at 20℃; for 24h;99%
With sodium hydride In tetrahydrofuran at 0 - 20℃;98%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Boc-Val-ONSu
3392-12-9

Boc-Val-ONSu

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 72h; Inert atmosphere; Sealed tube;100%
In tetrahydrofuran at 0 - 20℃; for 16h;72%
With dicyclohexyl-carbodiimide In 1,2-dimethoxyethane at 5℃; for 6h;69.5%
chlorosulfuric acid chloromethyl ester
49715-04-0

chlorosulfuric acid chloromethyl ester

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

N-tert-butyloxycarbonyl-L-valine chloromethyl ester
40224-39-3

N-tert-butyloxycarbonyl-L-valine chloromethyl ester

Conditions
ConditionsYield
Stage #1: t-Boc-L-valine With tetra(n-butyl)ammonium hydrogensulfate; sodium hydrogencarbonate In dichloromethane; water at 0℃; for 0.166667h;
Stage #2: chlorosulfuric acid chloromethyl ester In dichloromethane; water at 0 - 20℃; for 19.3333h;
100%
With tetra(n-butyl)ammonium hydrogensulfate; sodium carbonate In dichloromethane; water at 0 - 20℃; for 19.33h;100%
Stage #1: t-Boc-L-valine With tetra(n-butyl)ammonium hydrogensulfate; sodium hydrogencarbonate In dichloromethane; water at 20℃; for 0.0833333h;
Stage #2: chlorosulfuric acid chloromethyl ester In dichloromethane; water at 0 - 20℃; for 2h;
99%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

glycine ethyl ester hydrochloride
5680-79-5

glycine ethyl ester hydrochloride

methyl 2-((2S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanamido)acetate
51803-69-1

methyl 2-((2S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanamido)acetate

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; Inert atmosphere;100%
With cyano-hydroxyimino-acetic acid 2,2-dimethyl-[1,3]dioxolan-4-ylmethyl ester; sodium hydrogencarbonate; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In water at 20℃; for 2h; optical yield given as %de;95%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; Inert atmosphere;91%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

methyl (2S)-2-amino-3-phenylpropanoate hydrochloride
7524-50-7

methyl (2S)-2-amino-3-phenylpropanoate hydrochloride

N-tert-butoxycarbonyl-L-valyl-L-phenylalanine methyl ester
20902-47-0

N-tert-butoxycarbonyl-L-valyl-L-phenylalanine methyl ester

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane at 20℃; for 24h;100%
Stage #1: t-Boc-L-valine With 2,6-dimethylpyridine; 6-chloro-3-((dimethylamino)(dimethyliminio)methyl)-1H-benzo[d][1,2,3]triazol-3-ium-1-olatehexafluorophosphate(V); 6-chloro-1-hydroxybenzotriazole In dichloromethane; N,N-dimethyl-formamide at 0℃; for 0.166667h;
Stage #2: methyl (2S)-2-amino-3-phenylpropanoate hydrochloride With 2,6-dimethylpyridine In dichloromethane; N,N-dimethyl-formamide
97%
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In tetrahydrofuran; acetonitrile at 20℃; for 3h;89%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

L-isoleucine benzyl ester tosylate
16652-75-8

L-isoleucine benzyl ester tosylate

(2S,3S)-benzyl-2-{(S)-2-[(tert-butoxycarbonyl)amino]-3-methyl-butanamido}-3-methylpentanoate

(2S,3S)-benzyl-2-{(S)-2-[(tert-butoxycarbonyl)amino]-3-methyl-butanamido}-3-methylpentanoate

Conditions
ConditionsYield
With benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; triethylamine In water; N,N-dimethyl-formamide for 16h; molar ratio: HOBt:Boc-Val-OH=1:10;100%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In 1,2-dichloro-ethane for 1h; Product distribution; Ambient temperature; other additives, other solvents;82%
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In tetrahydrofuran at 0 - 20℃; for 12h;74%
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃; for 2h;
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

N,O-dimethylhydroxylamine*hydrochloride
6638-79-5

N,O-dimethylhydroxylamine*hydrochloride

tert-butyl (S)-1-(N-methoxy-N-methylcarbamoyl)-2-methylpropylcarbamate
87694-52-8

tert-butyl (S)-1-(N-methoxy-N-methylcarbamoyl)-2-methylpropylcarbamate

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In N,N-dimethyl-formamide at 4℃;100%
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 0 - 20℃;100%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

(S)-4-isopropyloxazolidine-2,5-dione
24601-74-9

(S)-4-isopropyloxazolidine-2,5-dione

Conditions
ConditionsYield
With phosphorus trichloride In dichloromethane at 0℃; for 2h;100%
With bis(trichloromethyl) carbonate; triethylamine In ethyl acetate for 3h; Ambient temperature;75%
Multi-step reaction with 2 steps
1: 50 percent / N-ethyl,N'-(γ-dimethylaminopropyl)-carbodiimide*HCl, triethylamine*HCl / CH2Cl2
2: 90 percent / HCl / CH2Cl2 / 0 °C
View Scheme
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

N-hydroxy-5-norbornene-2,3-dicarboximide
21715-90-2

N-hydroxy-5-norbornene-2,3-dicarboximide

N-(t-butoxycarbonyl)-L-valine N-hydroxy-5-norbornene-2,3-dicarboximide ester
66714-48-5, 68967-04-4

N-(t-butoxycarbonyl)-L-valine N-hydroxy-5-norbornene-2,3-dicarboximide ester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In N,N-dimethyl-formamide; acetonitrile 1.) 0 deg C, 1 h, 2.) RT, 4 h;100%
With WSCD*HCl In N,N-dimethyl-formamide; acetonitrile at 0℃; for 1h;
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

C16H33NO4Si
130529-82-7

C16H33NO4Si

Conditions
ConditionsYield
With triethylamine In ethyl acetate at 0℃; for 0.5h;100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

methyl 2-amino-3-hydroxypropanoate hydrochloride
5619-04-5

methyl 2-amino-3-hydroxypropanoate hydrochloride

2-((S)-2-tert-Butoxycarbonylamino-3-methyl-butyrylamino)-3-hydroxy-propionic acid methyl ester
793727-88-5

2-((S)-2-tert-Butoxycarbonylamino-3-methyl-butyrylamino)-3-hydroxy-propionic acid methyl ester

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In acetonitrile at 20℃; for 12.0833h;100%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In acetonitrile at 20℃; for 12h;100%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In acetonitrile at 20℃; for 12h;100%
With triethylamine; isobutyl chloroformate 1) THF, -30 deg C, 30 min; 2) THF, -30 deg C --> rt, 6 h, rt, 12 h; Yield given. Multistep reaction;
Stage #1: t-Boc-L-valine With triethylamine; isobutyl chloroformate In tetrahydrofuran at -30℃; for 1h;
Stage #2: methyl 2-amino-3-hydroxypropanoate hydrochloride In tetrahydrofuran at -30 - 20℃; Further stages.;
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
3945-69-5

4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride

2-tert-butoxycarbonylamino-3-methyl-butyric acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester
345911-01-5

2-tert-butoxycarbonylamino-3-methyl-butyric acid 4,6-dimethoxy-[1,3,5]triazin-2-yl ester

Conditions
ConditionsYield
In 1,2-dimethoxyethane at 0℃; for 3h; Condensation;100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

benzylamine
100-46-9

benzylamine

tert-butyl (S)-1-(benzylamino)-3-methyl-1-oxobutan-2-ylcarbamate
67106-22-3

tert-butyl (S)-1-(benzylamino)-3-methyl-1-oxobutan-2-ylcarbamate

Conditions
ConditionsYield
100%
Stage #1: t-Boc-L-valine With chloroformic acid ethyl ester; triethylamine at 0℃; for 1h; Inert atmosphere;
Stage #2: benzylamine at 0 - 20℃; for 2h; Inert atmosphere;
92%
Stage #1: t-Boc-L-valine With chloroformic acid ethyl ester; triethylamine In dichloromethane at 0℃; for 1h; Inert atmosphere;
Stage #2: benzylamine In dichloromethane at 20℃; for 2h; Inert atmosphere;
90%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

(3aR,6aS)-1-(cyclopropylcarbonyl)-3,3-dimethylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one hydrochloride

(3aR,6aS)-1-(cyclopropylcarbonyl)-3,3-dimethylhexahydropyrrolo[3,2-b]pyrrol-2(1H)-one hydrochloride

tert-butyl (1S)-{[(3aS,6aR)-4-(cyclopropylcarbonyl)-6,6-dimethyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl}-2-methylpropylcarbamate
488748-91-0

tert-butyl (1S)-{[(3aS,6aR)-4-(cyclopropylcarbonyl)-6,6-dimethyl-5-oxohexahydropyrrolo[3,2-b]pyrrol-1(2H)-yl]carbonyl}-2-methylpropylcarbamate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In acetonitrile at 20℃;100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

C13H20N2O2

C13H20N2O2

C23H37N3O5

C23H37N3O5

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In acetonitrile100%
pyrrolidine
123-75-1

pyrrolidine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

(S)-tert-butyl 3-methyl-1-oxo-1-(pyrrolidin-1-yl)butan-2-ylcarbamate
130013-62-6

(S)-tert-butyl 3-methyl-1-oxo-1-(pyrrolidin-1-yl)butan-2-ylcarbamate

Conditions
ConditionsYield
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine In acetonitrile at 20℃;100%
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃;82%
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 24.4167h; Inert atmosphere;82%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Propargylamine
2450-71-7

Propargylamine

(S)-2-methyl-1-(prop-2-ynylcarbamoyl)-propylcarbamic acid t-butyl ester
810671-37-5

(S)-2-methyl-1-(prop-2-ynylcarbamoyl)-propylcarbamic acid t-butyl ester

Conditions
ConditionsYield
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In dichloromethane for 2h; Inert atmosphere; Reflux;100%
Stage #1: t-Boc-L-valine With 4-methyl-morpholine; isobutyl chloroformate In dichloromethane at -20℃; for 1h;
Stage #2: Propargylamine In dichloromethane at 20℃; for 16h; Further stages.;
99%
With benzotriazol-1-ol; diisopropyl-carbodiimide In dichloromethane at 0 - 20℃; for 16h; Inert atmosphere;97%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

L-valine benzyl ester p-toluenesulfonate salt
16652-76-9

L-valine benzyl ester p-toluenesulfonate salt

(S)-benzyl 2-((S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanamido)-3-methylbutanoate
77443-49-3

(S)-benzyl 2-((S)-2-((tert-butoxycarbonyl)amino)-3-methylbutanamido)-3-methylbutanoate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine100%
With benzotriazol-1-ol; dicyclohexyl-carbodiimide In tetrahydrofuran at 20℃;99%
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In tetrahydrofuran at 0 - 20℃; for 12h;87%
With triethylamine; dicyclohexyl-carbodiimide In N,N-dimethyl-formamide at 20℃; for 5h;26%
With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In tetrahydrofuran at 0 - 20℃; for 12h; Inert atmosphere;
H-Asp(TMSE)-OBn

H-Asp(TMSE)-OBn

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Boc-Val-Asp(TMSE)-OBn

Boc-Val-Asp(TMSE)-OBn

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 0.75h;100%
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 2h;99%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

Boc-Val-OBt
68754-63-2

Boc-Val-OBt

Conditions
ConditionsYield
With O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃;100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

((S)-1-{(S)-4-benzyl-2-[(R)-(1,2,3,4-tetrahydro-naphthalen-1-yl)carbamoyl]-piperazine-1-carbonyl}-2-methyl-propyl)-carbamic acid tert-butyl ester
913359-77-0

((S)-1-{(S)-4-benzyl-2-[(R)-(1,2,3,4-tetrahydro-naphthalen-1-yl)carbamoyl]-piperazine-1-carbonyl}-2-methyl-propyl)-carbamic acid tert-butyl ester

Conditions
ConditionsYield
Stage #1: (S)-4-benzyl-piperazine-2-carboxylic acid [(1R)-1,2,3,4-tetrahydro-naphthalen-1-yl]-amide With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 1h;
Stage #2: t-Boc-L-valine In N,N-dimethyl-formamide for 1h;
Stage #3: With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate In N,N-dimethyl-formamide at 20℃;
100%
4-N-(tert-butoxycarbonyl)-3'-O-(tert-butyldimethylsilyl)-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine
903561-50-2

4-N-(tert-butoxycarbonyl)-3'-O-(tert-butyldimethylsilyl)-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

4-N-(tert-butoxycarbonyl)-5'-O-[N-(tert-butoxycarbonyl)-L-valyl]-3'-O-(tert-butyldimethylsilyl)-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine
903561-55-7

4-N-(tert-butoxycarbonyl)-5'-O-[N-(tert-butoxycarbonyl)-L-valyl]-3'-O-(tert-butyldimethylsilyl)-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine

Conditions
ConditionsYield
With dmap; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane at 0℃; for 3h;100%
4-N-(tert-butoxycarbonyl)-3'-O-(dimethyl-t-hexylsilyl)-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine
903561-53-5

4-N-(tert-butoxycarbonyl)-3'-O-(dimethyl-t-hexylsilyl)-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

4-N-(tert-butoxycarbonyl)-3'-O-(dimethyl-t-hexylsilyl)-5'-O-[N-(tert-butoxycarbonyl)-L-valyl]-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine
903561-54-6

4-N-(tert-butoxycarbonyl)-3'-O-(dimethyl-t-hexylsilyl)-5'-O-[N-(tert-butoxycarbonyl)-L-valyl]-2'-cyano-2'-deoxy-1-β-D-arabinofuranosylcytosine

Conditions
ConditionsYield
With dmap; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane at 0℃; for 4h;100%
1-(tert-butoxycarbonyl)-L-proline
15761-39-4

1-(tert-butoxycarbonyl)-L-proline

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N-tert-butoxycarbonyl-L-leucine
13139-15-6

N-tert-butoxycarbonyl-L-leucine

N-tert-butoxycarbonyl-L-phenylalanine
13734-34-4

N-tert-butoxycarbonyl-L-phenylalanine

H-Hphe-Leu-Ile-Ile-Leu-Val-Pro-Pro-Phe-OH
1187223-35-3

H-Hphe-Leu-Ile-Ile-Leu-Val-Pro-Pro-Phe-OH

Conditions
ConditionsYield
Stage #1: Boc-L-homophenylalanine solid phase reaction;
Stage #2: With trifluoroacetic acid In dichloromethane solid phase reaction;
Stage #3: 1-(tert-butoxycarbonyl)-L-proline; t-Boc-L-valine; N-(tert-butyloxycarbonyl)-L-isoleucine; N-tert-butoxycarbonyl-L-leucine; N-tert-butoxycarbonyl-L-phenylalanine Further stages;
100%
1-(tert-butoxycarbonyl)-L-proline
15761-39-4

1-(tert-butoxycarbonyl)-L-proline

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

N-(tert-butyloxycarbonyl)-L-isoleucine
13139-16-7

N-(tert-butyloxycarbonyl)-L-isoleucine

N-tert-butoxycarbonyl-L-leucine
13139-15-6

N-tert-butoxycarbonyl-L-leucine

N-tert-butoxycarbonyl-L-phenylalanine
13734-34-4

N-tert-butoxycarbonyl-L-phenylalanine

H-Ile-Ile-Leu-Val-Pro-Pro-Hphe-Hphe-Leu-OH
1187223-36-4

H-Ile-Ile-Leu-Val-Pro-Pro-Hphe-Hphe-Leu-OH

Conditions
ConditionsYield
Stage #1: N-tert-butoxycarbonyl-L-leucine solid phase reaction;
Stage #2: With trifluoroacetic acid In dichloromethane solid phase reaction;
Stage #3: 1-(tert-butoxycarbonyl)-L-proline; t-Boc-L-valine; N-(tert-butyloxycarbonyl)-L-isoleucine; N-tert-butoxycarbonyl-L-phenylalanine; Boc-L-homophenylalanine Further stages;
100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

L-alanine benzyl ester p-toluenesulfonate
42854-62-6

L-alanine benzyl ester p-toluenesulfonate

Boc-Val-Ala-OBzl
77946-33-9

Boc-Val-Ala-OBzl

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine100%
methanol
67-56-1

methanol

t-Boc-L-valine
13734-41-3

t-Boc-L-valine

L-valine methylester hydrochloride
6306-52-1

L-valine methylester hydrochloride

Conditions
ConditionsYield
With thionyl chloride at 0 - 20℃;100%
With thionyl chloride at 20℃; Cooling;
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

4-{5-fluoro-2-[(piperidin-4-yl)oxy]phenyl}morpholine hydrochloride
1189551-08-3

4-{5-fluoro-2-[(piperidin-4-yl)oxy]phenyl}morpholine hydrochloride

t-Butyl [(1S)-1-{[4-(4-fluoro-2-morpholin-4-ylphenoxy)piperidin-1-yl]carbonyl}-2-methylpropyl]carbamate
1189551-09-4

t-Butyl [(1S)-1-{[4-(4-fluoro-2-morpholin-4-ylphenoxy)piperidin-1-yl]carbonyl}-2-methylpropyl]carbamate

Conditions
ConditionsYield
100%
t-Boc-L-valine
13734-41-3

t-Boc-L-valine

t-butyl 4-[4-fluoro-2-(methoxycarbonyl)phenoxy]piperidine-1-carboxylate
1189550-98-8

t-butyl 4-[4-fluoro-2-(methoxycarbonyl)phenoxy]piperidine-1-carboxylate

methyl 2-({1-[N-(t-butoxycarbonyl)-L-valyl]piperidin-4-yl}oxy)-5-fluorobenzoate
1189551-00-5

methyl 2-({1-[N-(t-butoxycarbonyl)-L-valyl]piperidin-4-yl}oxy)-5-fluorobenzoate

Conditions
ConditionsYield
Product distribution / selectivity;100%

13734-41-3Relevant articles and documents

The role of the disulfide bond in amyloid-like fibrillogenesis in a model peptide system

Das, Apurba Kumar,Drew, Michael G. B.,Haldar, Debasish,Banerjee, Arindam

, p. 3502 - 3507 (2005)

Three terminally protected short peptides Bis[Boc-D-Leu(1)-Cys(2)-OMe] 1, Bis[Boc-Leu(1)-Cys(2)-OMe] 2 and Bis[Boc-Val(1)-Cys(2)-OMe] 3 exhibit amyloid-like fibrillar morphology. Single crystal X-ray diffraction analysis of peptide 1 clearly demonstrates that it adopts an overall extended backbone molecular conformation that self-assembles to form an intermolecular hydrogen-bonded antiparallel supramolecular β-sheet structure in crystals. Scanning electron microscopic (SEM) images, transmission electron microscopic (TEM) images and Congo red binding studies vividly demonstrate the amyloid-like fibril formation of peptides 1, 2 and 3. However, after reduction of the disulfide bridge of peptides 1, 2 and 3, three newly generated peptides Boc-D-Leu(1)-Cys(2)-OMe 4, Boc-Leu(1)-Cys(2)-OMe 5 and Boc-Val(1)-Cys(2)-OMe 6 are formed and all of them failed to form any kind of fibril under the same conditions, indicating the important role of the disulfide bond in amyloid-like fibrillogenesis in a peptide model system. The Royal Society of Chemistry 2005.

Anthracene-labeled pyridinium-based symmetrical chiral chemosensor for enantioselective recognition of l-tartrate

Ghosh, Kumaresh,Sarkar, Tanmay

, p. 1342 - 1346 (2014)

A new anthracene-based chiral chemosensor 1 has been designed and synthesized. l-Valine has been used as the chiral source in the design. The chemosensor 1 has been established as an efficient enantioselective sensor for l-tartrate. While in the presence of l-tartrate the fluorescent sensor 1 in DMSO exhibits considerable increase in emission, the isomeric tartrate brings relatively small change. The enantiomeric fluorescence difference ratio (ef) has been determined to be 29.38.

A short water-soluble self-assembling peptide forms amyloid-like fibrils

Ray, Sudipta,Das, Apurba K.,Drew, Michael G. B.,Banerjee, Arindam

, p. 4230 - 4232 (2006)

A water-soluble tripeptide Val-Ile-Ala (VIA) 1, bearing sequence identity with the C-terminal portion of the Alzheimer Aβ-peptide (Aβ40-42), self-assembles, in crystalline form, to produce an intermolecularly hydrogen bonded supramolecular β-sheet structure which self-associates to form straight, unbranched nanofibrils exhibiting amyloid-like behavior; in contrast, the synthetic tripeptide Ala-Val-Ile (AVI) 2 self-assembles to produce a β-sheet structure that forms branched nanofibrils which do not show any characteristic features of amyloid-like fibrils. The Royal Society of Chemistry 2006.

Enantioselective sensing of lactate by pyridinium-based chiral receptor

Ghosh, Kumaresh,Majumdar, Anupam

, p. 5686 - 5689 (2013)

A simple pyridinium-based chiral receptor 1 containing l-valine as the chiral source has been designed and synthesized. The receptor 1 fluorometrically recognizes d-lactate over l-lactate in CH3CN with an enantiomeric fluorescence ratio (ef) of 5.32.

Synthesis and biological evaluation of new pleuromutilin derivatives as antibacterial agents

Shang, Ruo-Feng,Wang, Guan-Hua,Xu, Xi-Ming,Liu, Si-Jie,Zhang, Chao,Yi, Yun-Peng,Liang, Jian-Ping,Liu, Yu

, p. 19050 - 19065 (2014)

Several pleuromutilin derivatives possessing thiadiazole moieties were synthesized via acylation reactions under mild conditions. The in vitro antibacterial activities of the derivatives against methicillin-resistant S. aureus, methicillin-resistant S. epidermidis, S. aureus, S. epidermidis, E. coli, and B. cereus were tested by the agar dilution method and Oxford cup assay. All the screened compounds displayed potent activity. Compound 6d was the most active antibacterial agent because of its lowest MIC value and largest inhibition zone. Docking experiments were performed to understand the possible mode of the interactions between the derivatives and 50S ribosomal subunit. Moreover, the absorption, distribution, metabolism, excretion and toxicity properties of the synthesized compounds were analyzed after prediction using the Advanced Chemistry Development/Percepta Platform available online.

Heating reactions of N-t-Butyloxycarbonyl-Asparagine and related compounds

Munegumi,Akao,Kawatu,Yamada,Harada

, p. 6541 - 6548 (2014)

N-t-Butyloxycarbonyl-amino acids (Boc-) are labile on heating to afford free amino acids, but Boc-aspartic acid gives a kind of polypeptide. This chemical feature of Boc-aspartic acid may be caused by dehydration between two carboxyl groups as well as the formation of a free amino group. Boc-Asparagine may have a similar reactivity to Boc-aspartic acid. This research describes polypeptide formation by heating Boc-asparagine and its isomer Boc-aspartic acid amide.

PRODRUGS OF ABIRATERONE

-

Page/Page column 21, (2021/05/29)

The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers, or pharmaceutically acceptable salt(s) thereof as prodrugs of abiraterone. The present invention also describes method of making such compounds, pharmaceutical compositions comprising such compounds and the use of the compounds of formula (I).

Convenient Synthesis of Alternatively Bridged Tryptophan Ketopiperazines and Their Activities against Trypanosomatid Parasites

Cockram, Peter E.,Slawin, Alexandra M. Z.,Smith, Terry K.,Turner, Callum A.

supporting information, (2022/01/11)

There is an urgent need for the development of new treatments against trypanosomatid parasites; the causative agents of some of the most debilitating diseases in the developing world. This work targets an interesting 6-5-6-6 fused carboline scaffold, accessing a range of substituted derivatives through stereospecific intramolecular Pictet–Spengler condensation. Modification of the cyclisation conditions allowed retention of the carbamate protecting group and gave insight into the reaction mechanism. Compounds’ bioactivities were measured against T. brucei, T. cruzi, L. major and HeLa cells. We have identified promising pan-trypanocidal lead compounds based on the core scaffold, and highlight key SAR trends which will be useful for the future development of these compounds as potent trypanocidal agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13734-41-3